Blue Line Standard Service - Subscriber Page

Special Update: TWLO

  The TWLO May $125 call reached its +35% profit-taking level today. It was up as high as +40% and is trading at about +25% an hour before the clos...

Wednesday Update: Potpourri

  Trading System Of the 25 May and June expirations six have been stopped out at -75%, nine have reached +35% and 10 remain open between those two ...

Monday Update: New Trade

  Sell Signal HPQ Option: June $20 Put (around $0.90) HPQ fell from $24 to $18.50 in the days following the release of earnings in February. It has...

Updated Trading Tables

  Here are the updated Trade Tables for both services. The Premium Service continues to be the more robust of the two, having had two of its newest...

Wednesday Update

  The market will be closed on Friday in observance of Good Friday. The significance is two-fold, I will take Easter weekend off and therefore no W...

TLT/TBT Alert

  Someone bought 10K TLT May $122 puts today. (Was it a subscriber?) What do they know?  I still like these trades, TLT puts and/or TBT calls, whet...

Monday Special Update

  After I trashed TLT in the Weekend Update, a subscriber asked what I thought of TBT, the leveraged inverse fund of TLT, on the long side with cal...

Weekend Update: Special Situation

  When one trend ends, another begins. Almost by definition, that last trading signal in an expiring trend will be wrong, it has to be. The trading...

Daily Update

  No new trades.  We are on the cusp of rolling out a new App that will notify subscribers of any new trades so you won't have to check your email ...

Daily Update: GBTC

  GBTC - The Grayscale Bitcoin Trust is running, along with the price of bitcoin.  It's not too late to get in as bitcoin seems to be back in a str...

Daily Update

  Below is a chart of TWLO. The set-up is coming together for a strong BUY signal if it can close above $125 (currently trading at $122). I'm willi...

New Biotech

  "The research was funded by The Damon Runyon Cancer Research Foundation, the Cancer Research Institute and Merck. Celldex and Oncovir provided th...